Produkt-Katalog [{"id":"596","name":"Augtyro","price":0,"sku":"Augtyro (repotrectinib)","brand":"Bristol-Myers Squibb","position":1,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"554","name":"Krazati","price":31981.5,"sku":"Krazati (adagrasib)","brand":false,"position":2,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"474","name":"Exkivity","price":30225,"sku":"Exkivity (mobocertinib)","brand":"Takeda Pharma A\/S","position":3,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"444","name":"Rybrevant","price":2230.41,"sku":"Rybrevant (amivantamab-vmjw)","brand":"Janssen Biotech","position":4,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"442","name":"Lumakras ","price":12392.91,"sku":"Lumakras (sotorasib)","brand":"Amgen Inc.","position":5,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"420","name":"Cosela","price":2581.69,"sku":"Cosela (trilaciclib)","brand":"G1 Pharmaceuticals, Inc.","position":6,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"353","name":"Tabrecta","price":17005.3,"sku":"Tabrecta (capmatinib)","brand":"Novartis Pharmaceuticals Corporation","position":7,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"351","name":"Zepzelca","price":12146.02,"sku":"Zepzelca (lurbinectedin)","brand":"Jazz Pharmaceuticals","position":8,"category":"Medicines\/Cancer\/Lung Cancer"},{"id":"248","name":"Lorviqua","price":4656.03,"sku":"Lorviqua (lorlatinib)","brand":"Pfizer Limited","position":9,"category":"Medicines\/Cancer\/Lung Cancer"}]

Optionen für den Zugang zu Medikamenten

  1. Zejula
    Zejula (niraparib)
    Gynäkologischer Krebs
    €5,986.42
  2. Xeljanz
    Xeljanz (tofacitinib)
    Rheumatoide Arthritis
    €1,198.35
  3. Tymlos
    Tymlos (abaloparatide)
    Osteoporose
    €3,220.00
  4. Tecentriq
    Tecentriq (Atezolizumab)
    Urothelkarzinom, Brustkrebs, Lungenkrebs
    €7,452.90
  5. Taltz
    Taltz (ixekizumab)
    Psoriasis
    €3,185.16
  6. Tagrisso
    Tagrisso (osimertinib)
    Lungenkrebs
    €6,838.00
  7. Spinraza
    Spinraza (Nusinersen)
    Spinale Muskelatrophie
    Preis auf Anfrage erhältlich
  8. Rydapt
    Rydapt (midostaurin)
    Leukämie
    €18,846.76
  9. Rubraca
    Rubraca (rucaparib)
    Gynäkologischer Krebs
    €2,021.44
  10. Portrazza
    Portrazza (necitumumab)
    Lungenkrebs
    €9,241.93
  11. Perjeta
    Perjeta (Pertuzumab)
    Brustkrebs
    €3,036.09
Ansicht als Raster Liste

Artikel 1-12 von 349

Absteigende Richtung einstellen
US 0